Sign in
4

Changes in Ownership

Tyra Biosciences, Inc. Filed Acc 0001209191-23-037611

Chief Operating Officer sold 18,340 shares at an average $16.11 ($295,405)

  • Chief Operating Officer acquired 18,340 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Bensen Daniel Chief Operating Officer 2023-06-13 Option exercise 10b5-1 +5,628 $0.61 $3,433 533,609 D
Bensen Daniel Chief Operating Officer 2023-06-13 Sale 10b5-1 −5,628 $16.01 $90,129 527,981 D
Bensen Daniel Chief Operating Officer 2023-06-14 Option exercise 10b5-1 +120 $0.61 $73 528,101 D
Bensen Daniel Chief Operating Officer 2023-06-14 Sale 10b5-1 −120 $16.45 $1,974 527,981 D
Bensen Daniel Chief Operating Officer 2023-06-15 Option exercise 10b5-1 +12,592 $0.61 $7,681 540,573 D
Bensen Daniel Chief Operating Officer 2023-06-15 Sale 10b5-1 −12,592 $16.15 $203,302 527,981 D
Derivatives
Bensen Daniel Chief Operating Officer 2023-06-13 Option exercise · Stock Option (Right to Buy) 10b5-1 −5,628 241,774 D
Bensen Daniel Chief Operating Officer 2023-06-14 Option exercise · Stock Option (Right to Buy) 10b5-1 −120 241,654 D
Bensen Daniel Chief Operating Officer 2023-06-15 Option exercise · Stock Option (Right to Buy) 10b5-1 −12,592 229,062 D
Open-market sales · 18,340 sh · avg $16.11 · $295,405
Loading xslF345X04/doc4.xml…